Stay updated on Acalabrutinib in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page shows a new revision number, moving from v3.5.3 to v3.5.4, indicating a small update to the page's version rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-05-15T02:19:59.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.2 to v3.5.3, indicating a minor template update.
    Difference
    0.1%
    Check dated 2026-04-30T15:55:18.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added “Ovarian cancer” related topics under MedlinePlus/MedlinePlus Genetics sections.
    Difference
    0.2%
    Check dated 2026-04-23T15:22:47.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:15:31.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:28:43.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The header revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:48:37.000Z thumbnail image

Stay in the know with updates to Acalabrutinib in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.